Ritter Pharmaceuticals
Ritter Pharmaceuticals discovers and commercializes treatments for gastrointestinal diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD20—30m (Dealroom.co estimates Dec 2014.)
Los Angeles California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | $500k | Series A | |
$1.0m | Seed | ||
| N/A | $453k | Debt | |
$2.0m | Seed | ||
| N/A | $244k | Grant | |
| N/A | $526k | Debt | |
| N/A | $3.9m | Seed | |
| N/A | $1.6m | Seed | |
$3.7m | Seed | ||
| N/A | N/A | IPO | |
$10.0m | Post IPO Equity | ||
| Total Funding | CAD17.7m | ||